| 000 | 00903 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250514164305.0 | ||
| 264 | 0 | _c20040226 | |
| 008 | 200402s 0 0 eng d | ||
| 022 | _a0017-5749 | ||
| 024 | 7 |
_a10.1136/gut.53.1.155 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aD'Haens, G | |
| 245 | 0 | 0 |
_aMesalazine is safe for the treatment of IBD. _h[electronic resource] |
| 260 |
_bGut _cJan 2004 |
||
| 300 |
_a155 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInflammatory Bowel Diseases _xdrug therapy |
| 650 | 0 | 4 |
_aMesalamine _xadverse effects |
| 650 | 0 | 4 |
_aSulfasalazine _xadverse effects |
| 700 | 1 | _avan Bodegraven, A A | |
| 773 | 0 |
_tGut _gvol. 53 _gno. 1 _gp. 155 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/gut.53.1.155 _zAvailable from publisher's website |
| 999 |
_c14416163 _d14416163 |
||